A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...
5d
Medicaid tries new approach with sickle cell: Companies only get paid if costly gene therapies work
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting ...
CHEROKEE COUNTY, Ga. — A Cherokee County man living with Sickle Cell Disease is now the first known person with the condition to get a medical pilot’s license. Channel 2’s Fred Blankenship spoke with ...
NASHVILLE, Tenn. (Ivanhoe Newswire) - Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United ...
INDIANAPOLIS (WISH) — For the first time, scientists say new therapies have the power to cure sickle cell disease. The disease is a devastating, inherited blood disorder that affects an estimated ...
Doctors say new gene-based treatments could offer long-term relief — and possible cures — for people living with sickle cell disease. Sickle cell disease has long shortened lives in the United States, ...
NASHVILLE, Tenn. (Ivanhoe Newswire) - Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United ...
Female adolescents and adults with sickle cell disease are at risk for a range of menstrual complications, especially pain and abnormal uterine bleeding. That’s according to the authors of a new multi ...
Chicago’s South Side residents now have access to a new sickle-cell treatment clinic at Roseland Community Hospital. On Monday, Roseland held a ribbon-cutting ceremony introducing Dr. Mahoud Mahafzah ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Nov 19 (Reuters) - Agios Pharmaceuticals (AGIO.O), opens new tab said on Wednesday its sickle cell disease drug met one of its two main goals in a late-stage study of patients aged 16 and older but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results